Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

NCT04414540 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Metformin Extended Release Oral Tablet
DRUG: Pembrolizumab

Sponsor

Trisha Wise-Draper

Collaborators

[object Object]